Literature DB >> 7891424

A schizophrenic patient who developed extreme hypothermia after an increase in the dose of haloperidol: a case report.

H Harada1, M Igarashi, S Sugae, K Okamoto, M Tsuji, T Nakajima.   

Abstract

A patient with chronic schizophrenia, who had been treated for a long time with chlorpromazine, haloperidol, levodopa, benserazide hydrochloride, diazepam and biperiden, developed extreme hypothermia (about 32 degrees C) when the dose of haloperidol was increased because of a deterioration of the patient's mental symptoms. No other physical manifestations were observed, except bradycardia. The turnover of noradrenaline in the cerebrospinal fluid and blood was increased in association with the hypothermia in this patient. A hypothesis about the involvement of monoamine imbalance in changes in body temperature is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7891424     DOI: 10.1111/j.1440-1819.1994.tb03020.x

Source DB:  PubMed          Journal:  Jpn J Psychiatry Neurol        ISSN: 0912-2036


  5 in total

1.  What about temperature? Haloperidol-induced hypotermia.

Authors:  Maria Salvina Signorelli; Federico Nalis; Mariacatena Battiato; Eugenio Aguglia
Journal:  BMJ Case Rep       Date:  2013-09-19

Review 2.  [Hypothermia under olanzapine treatment: clinical case series and review of current literature].

Authors:  P Kreuzer; M Landgrebe; M Wittmann; G Hajak; M Schecklmann; T B Poeppl; B Langguth
Journal:  Nervenarzt       Date:  2012-05       Impact factor: 1.214

Review 3.  Osborn waves in the electrocardiogram, hypothermia not due to exposure, and death due to diabetic ketoacidosis.

Authors:  Abdul M Sheikh; J Willis Hurst
Journal:  Clin Cardiol       Date:  2003-12       Impact factor: 2.882

Review 4.  Hypothermia following antipsychotic drug use.

Authors:  Rob J van Marum; Michelle A Wegewijs; Anton J M Loonen; Erna Beers
Journal:  Eur J Clin Pharmacol       Date:  2007-03-31       Impact factor: 2.953

5.  Hypothermia due to Antipsychotic Medication: A Systematic Review.

Authors:  Cherryl Zonnenberg; Jolien M Bueno-de-Mesquita; Dharmindredew Ramlal; Jan Dirk Blom
Journal:  Front Psychiatry       Date:  2017-09-07       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.